BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
Reprints
Medicare will cover Novo Nordisk's weight-loss drug Wegovy for heart patients, if prescribed to reduce their risk of heart attacks and strokes, Reuters reports. The U.S. Centers for Medicare and Medicaid Services said that obesity drugs, currently not covered by Medicare, would be paid for if they receive U.S. approval for a secondary use that Medicare does cover. The coverage of Wegovy will also open the drug up to government price negotiations under President Joe Biden's Inflation Reduction Act.
1. Hackers leak stolen data from Change Healthcare on dark web
2. UnitedHealth estimates $1.6 billion loss from Change cyberattack
3. UnitedHealth reports significant data breach; personal health info compromised
4. Ex-NBA player Will Bynum sentenced in insurance fraud scandal
5. Illinois House passes governor’s 'Healthcare Protection Act’
6. Analyst says Cigna, Humana share prices could put merger back on the table